Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $925.08 billion, total revenue of $174.57 billion and a weighted average PE ratio of 49.69.
Market Cap
925.08B
Revenue
174.57B
Profits
18.62B
PE Ratio
49.69
Profit Margin
10.66%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 249.14B | -0.40% | 2,039,972 | 47.35B |
| 2 | DHR | Danaher Corporation | 162.16B | 0.33% | 3,935,928 | 25.61B |
| 3 | NTRA | Natera, Inc. | 58.23B | 0.64% | 1,102,133 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 48.79B | -0.47% | 1,760,830 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 45.98B | 0.37% | 981,217 | 16.98B |
| 6 | WAT | Waters Corporation | 44.57B | -0.42% | 907,601 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 44.15B | -1.13% | 397,926 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 40.68B | 0.01% | 1,262,698 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 33.47B | -0.85% | 199,334 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 26.68B | -0.30% | 663,981 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 26.61B | -0.57% | 933,382 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 22.69B | 3.77% | 1,661,448 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.72B | 2.33% | 309,307 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 17.72B | 0.94% | 1,113,364 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.49B | 1.68% | 822,296 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 14.29B | -0.09% | 1,022,544 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 10.42B | 0.34% | 7,144,401 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 5.92B | 4.32% | 574,950 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.54B | 0.11% | 403,814 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.17B | -0.17% | 1,691,609 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 5.09B | 1.98% | 476,667 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.07B | 4.51% | 1,876,578 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.85B | 4.11% | 905,960 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.58B | 0.07% | 732,079 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.13B | 1.22% | 1,431,467 | 766.30M |
| 26 | PSNL | Personalis, Inc. | 1.69B | 0.19% | 1,115,836 | 69.67M |
| 27 | WGS | GeneDx Holdings Corp. | 1.67B | -16.37% | 2,563,527 | 454.43M |
| 28 | FRNM | Freenome, Inc. | 1.37B | -2.52% | 612,770 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.22B | - | 1,802,902 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.01B | -0.33% | 203,016 | 357.28M |
| 31 | MYGN | Myriad Genetics, Inc. | 556.68M | 1.04% | 2,099,977 | 806.60M |
| 32 | FLGT | Fulgent Genetics, Inc. | 553.06M | 0.55% | 240,057 | 323.93M |
| 33 | BDSX | Biodesix, Inc. | 223.47M | -11.53% | 139,515 | 102.94M |
| 34 | XGN | Exagen Inc. | 176.12M | -2.81% | 222,793 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 124.66M | -10.79% | 51,516 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 92.61M | -0.35% | 42,478 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 84.91M | -0.98% | 480,311 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 35.82M | -2.91% | 11,193 | 27.20M |
| 39 | MDXH | MDxHealth SA | 17.49M | -0.38% | 656,461 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.20M | 0.42% | 4,509 | - |
| 41 | XWEL | XWELL, Inc. | 5.86M | -0.16% | 36,145 | 28.28M |
| 42 | ADVB | Advanced Biomed Inc. | 5.24M | -8.38% | 22,358 | 127.64K |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.59M | -11.67% | 126,870 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.06M | -1.89% | 40,093 | 466.30K |